KRSA
Korsana Biosciences Inc.
KRSA | NASDAQ
$31.38
+$1.24 (+4.11%)
Nov 2, 2026, 3:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Net Income | -3.53M | -3.06M | -12.59M | -18.25M | -51.65M | -77.8M |
Depreciation & Amortization | n/a | n/a | 65K | 65K | 472K | 2.3M |
Stock-Based Compensation | 441K | 625K | n/a | n/a | 9.61M | 14.99M |
Other Working Capital | 99K | -537K | -2.93M | -4M | 988K | -7.84M |
Other Non-Cash Items | n/a | -363K | -4.12M | -19.58M | 3.64M | -4.39M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -227K | -1.54M | -4.6M | -2.85M | 1.41M | -7.59M |
Operating Cash Flow | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M | -72.49M |
Capital Expenditures | n/a | n/a | n/a | n/a | -7K | -1.52M |
Cash Acquisitions | n/a | n/a | 10.4M | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | 1.46M | 1.54M |
Investing Cash Flow | n/a | n/a | 10.4M | n/a | 1.46M | 18K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | 3.51M |
Common Stock Repurchased | -130K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 2.08M | n/a | n/a | n/a | 282K | 331K |
Financial Cash Flow | 3.32M | n/a | 5.02M | 29K | 30.79M | 28.09M |
Net Cash Flow | 8K | -4.34M | -5.81M | -40.58M | -4.27M | -44.39M |
Free Cash Flow | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M | -74.01M |
Adj. Free Cash Flow | -3.76M | -4.96M | -21.25M | -40.61M | -46.14M | -89.01M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | -1.52M |
Growth CapEx | n/a | n/a | n/a | n/a | -7K | n/a |
Owner Earnings | -3.31M | -4.33M | -21.25M | -40.61M | -36.52M | -74.01M |
Add to Watchlist
Select watchlists to add or remove KRSA